CVC is delighted to announce that it has appointed Christopher Bown to act as a Senior Adviser to CVC, following his stepping down from his role at Freshfields Bruckhaus Deringer in April 2014. Chris will be available to provide advice and assistance to all CVC deal teams and portfolio companies, working alongside our external counsel and in-house team as required.
As head of Freshfield's private equity practice Chris has acted for CVC on many occasions over the last eight years, and we are very pleased to be able to retain the benefit of his considerable experience and expertise for the firm in this new capacity.
Grupo GSH’S next stage of growth backed by leading global investor CVC
Mehiläinen agrees the acquisitions of Regina Maria and MediGroup and welcomes Hellman & Friedman as a new shareholder alongside CVC
CVC, Nordic Capital and ADIA complete acquisition of Hargreaves Lansdown to accelerate and enhance its transformation plan and deliver on its growth potential
Multiply Group signs landmark investment with CVC and PAI Partners to secure a controlling stake (67.91%) in Tendam, with the transaction expected to double Multiply’s operational EBITDA post-consolidation
PureHealth agrees to acquire Majority Stake in Hellenic Healthcare Group from funds managed by CVC Capital Partners and Management in EUR 2.2 Billion Transaction